Kadimastem Ltd
Kadimastem Ltd (KMSTF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KMSTF · as of Jun 8, 2026
Key Statistics
Explore Kadimastem Ltd Data
kmstf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
kmstf competitorsKMSTF
AMHV
ATHJF
EMMLF
NOXOF
OCELStock Performance
Full HistoryAbout Kadimastem Ltd
Kadimastem Ltd a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipel…
what is kadimastem ltd · kmstf stock overview · kadimastem ltd company profile · who is kadimastem ltd ceo · kmstf OTC · kadimastem ltd headquarters · kadimastem ltd business segments
About Stock Overview & Key Data
Kadimastem Ltd (KMSTF) is a Healthcare company in the Biotechnology industry, listed on OTC since Feb 1, 2021. As of the latest trading session, KMSTF stock price is $3.21, with a market capitalization of $9.5M. The stock has returned -64.61% over the past 12 months and -64.61% year-to-date.
In fiscal year 2024, Kadimastem Ltd reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Kadimastem Ltd (KMSTF) stock price is $3.21. The stock is traded on OTC under the ticker symbol KMSTF. The 52-week range is $0.64 – $9.07.